Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ki.2014.159 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply: Prognostic significance of preoperative exercise tolerance in patients with early-stage lung cancer.
J Thorac Cardiovasc Surg
December 2024
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Triplett et al reply.
Am J Health Syst Pharm
December 2024
Belmont University College of Pharmacy and Health Sciences, Nashville, TN, USA.
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
View Article and Find Full Text PDFLetter: Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease-Authors' Reply.
Aliment Pharmacol Ther
December 2024
Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Letter to the Editor Reply to "Accurate Predictory Role of Sarcopenia for the Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma," by Zhang.
Ann Surg Oncol
December 2024
The Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Reply to: "ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative hepatitis B patients with Peg-IFNα based therapy".
J Hepatol
December 2024
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!